UroSEEK gene panel for bladder cancer surveillance

Affiliations

Editorial

Regan Wong et al. Transl Androl Urol. 2019 Dec.

. 2019 Dec;8(Suppl 5):S546-S549.

doi: 10.21037/tau.2019.12.41.

¹ Department of Surgery & Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

No abstract available

Conflict of interest statement

Conflicts of Interest: Charles J. Rosser is an officer for the Nonagen Bioscience Corp. R Wong has no conflicts of interest to declare.

Incidence and distribution of UroSEEK gene panel in a multi-institutional cohort of bladder urothelial carcinoma.
Eich ML, Rodriguez Pena MDC, Springer SU, Taheri D, Tregnago AC, Salles DC, Bezerra SM, Cunha IW, Fujita K, Ertoy D, Bivalacqua TJ, Tomasetti C, Papadopoulos N, Kinzler KW, Vogelstein B, Netto GJ. Eich ML, et al. Mod Pathol. 2019 Oct;32(10):1544-1550. doi: 10.1038/s41379-019-0276-y. Epub 2019 Apr 25. Mod Pathol. 2019. PMID: 31028363 Free PMC article.

Serum Epiplakin Might Be a Potential Serodiagnostic Biomarker for Bladder Cancer.
Shimura S, Matsumoto K, Shimizu Y, Mochizuki K, Shiono Y, Hirano S, Koguchi D, Ikeda M, Sato Y, Iwamura M. Shimura S, et al. Cancers (Basel). 2021 Oct 14;13(20):5150. doi: 10.3390/cancers13205150. Cancers (Basel). 2021. PMID: 34680299 Free PMC article.
Liquid Biopsy Biomarkers in Urine: A Route towards Molecular Diagnosis and Personalized Medicine of Bladder Cancer.
Ferro M, La Civita E, Liotti A, Cennamo M, Tortora F, Buonerba C, Crocetto F, Lucarelli G, Busetto GM, Del Giudice F, de Cobelli O, Carrieri G, Porreca A, Cimmino A, Terracciano D. Ferro M, et al. J Pers Med. 2021 Mar 23;11(3):237. doi: 10.3390/jpm11030237. J Pers Med. 2021. PMID: 33806972 Free PMC article. Review.
Metabolomic Signatures of Treatment Response in Bladder Cancer.
Vieira de Sousa T, Guedes de Pinho P, Pinto J. Vieira de Sousa T, et al. Int J Mol Sci. 2023 Dec 16;24(24):17543. doi: 10.3390/ijms242417543. Int J Mol Sci. 2023. PMID: 38139377 Free PMC article. Review.
Molecular Oncology of Bladder Cancer from Inception to Modern Perspective.
Lokeshwar SD, Lopez M, Sarcan S, Aguilar K, Morera DS, Shaheen DM, Lokeshwar BL, Lokeshwar VB. Lokeshwar SD, et al. Cancers (Basel). 2022 May 24;14(11):2578. doi: 10.3390/cancers14112578. Cancers (Basel). 2022. PMID: 35681556 Free PMC article. Review.

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin 2019;69:7-34. 10.3322/caac.21551 - DOI - PubMed
1. Jemal A, Thomas A, Murray T, et al. Cancer statistics, 2002. CA Cancer J Clin 2002;52:23-47. 10.3322/canjclin.52.1.23 - DOI - PubMed
1. IARC. The Global Cancer Observatory (GCO) is an interactive web-based platform presenting global cancer statistics to inform cancer control and research. Available online: http://globocan.iarc.fr/Pages/summary_table_site_sel.aspx
1. Hall MC, Chang SS, Dalbagni G, et al. Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update. J Urol 2007;178:2314-30. 10.1016/j.juro.2007.09.003 - DOI - PubMed
1. Cancer Genome Atlas Research Network Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 2014;507:315-22. 10.1038/nature12965 - DOI - PMC - PubMed